HomeCompareARHCF vs PLD

ARHCF vs PLD: Dividend Comparison 2026

ARHCF yields 3.73% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $6.39M in total portfolio value
10 years
ARHCF
ARHCF
● Live price
3.73%
Share price
$11.87
Annual div
$0.44
5Y div CAGR
38%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$110.0K
Annual income
$35,436.17
Full ARHCF calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — ARHCF vs PLD

📍 PLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodARHCFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ARHCF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ARHCF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARHCF
Annual income on $10K today (after 15% tax)
$317.42/yr
After 10yr DRIP, annual income (after tax)
$30,120.74/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, PLD beats the other by $4,437,850.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARHCF + PLD for your $10,000?

ARHCF: 50%PLD: 50%
100% PLD50/50100% ARHCF
Portfolio after 10yr
$3.31M
Annual income
$2,645,936.17/yr
Blended yield
80.01%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

ARHCF
No analyst data
Altman Z
2.7
Piotroski
4/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARHCF buys
0
PLD buys
0
No recent congressional trades found for ARHCF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricARHCFPLD
Forward yield3.73%3.18%
Annual dividend / share$0.44$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR38%74.4%
Portfolio after 10y$110.0K$6.50M
Annual income after 10y$35,436.17$5,256,436.18
Total dividends collected$81.4K$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: ARHCF vs PLD ($10,000, DRIP)

YearARHCF PortfolioARHCF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$11,215$515.34$11,255$555.24$40.00PLD
2$12,746$745.43$13,062$1,018.59$316.00PLD
3$14,731$1,092.59$15,903$1,926.67$1.2KPLD
4$17,390$1,628.56$20,839$3,823.32$3.4KPLD
5$21,087$2,479.63$30,464$8,166.08$9.4KPLD
6$26,441$3,877.88$52,054$19,457.30$25.6KPLD
7$34,563$6,271.21$109,886$54,188.93$75.3KPLD
8$47,555$10,572.56$304,030$186,451.18$256.5KPLD
9$69,645$18,761.12$1,166,125$840,813.32$1.10MPLD
10$109,957$35,436.17$6,504,190$5,256,436.18$6.39MPLD

ARHCF vs PLD: Complete Analysis 2026

ARHCFStock

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.

Full ARHCF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this ARHCF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARHCF vs SCHDARHCF vs JEPIARHCF vs OARHCF vs KOARHCF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.